These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24363762)

  • 1. Stimulation of TLR4 by LMW-HA induces metastasis in human papillary thyroid carcinoma through CXCR7.
    Dang S; Peng Y; Ye L; Wang Y; Qian Z; Chen Y; Wang X; Lin Y; Zhang X; Sun X; Wu Q; Cheng Y; Nie H; Jin M; Xu H
    Clin Dev Immunol; 2013; 2013():712561. PubMed ID: 24363762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
    Zhang H; Teng X; Liu Z; Zhang L; Liu Z
    J Exp Clin Cancer Res; 2015 Feb; 34(1):16. PubMed ID: 25887589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemokine receptor CXCR7 is a critical regulator for the tumorigenesis and development of papillary thyroid carcinoma by inducing angiogenesis in vitro and in vivo.
    Zhang H; Yang L; Teng X; Liu Z; Liu C; Zhang L; Liu Z
    Tumour Biol; 2016 Feb; 37(2):2415-23. PubMed ID: 26383519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of CXCR7 expression mediated by TLR4 promotes tumor cell proliferation and migration in human colorectal carcinoma.
    Xu H; Wu Q; Dang S; Jin M; Xu J; Cheng Y; Pan M; Wu Y; Zhang C; Zhang Y
    PLoS One; 2011; 6(12):e27399. PubMed ID: 22180778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of CXCR7 in modulating the progression of papillary thyroid carcinoma.
    Liu Z; Yang L; Teng X; Zhang H; Guan H
    J Surg Res; 2014 Oct; 191(2):379-88. PubMed ID: 24814201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPS-induced CXCR7 expression promotes gastric Cancer proliferation and migration via the TLR4/MD-2 pathway.
    Li N; Xu H; Ou Y; Feng Z; Zhang Q; Zhu Q; Cai Z
    Diagn Pathol; 2019 Jan; 14(1):3. PubMed ID: 30636642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of stromal cell-derived factor 1 and CXCR7 in papillary thyroid carcinoma.
    Liu Z; Sun DX; Teng XY; Xu WX; Meng XP; Wang BS
    Endocr Pathol; 2012 Dec; 23(4):247-53. PubMed ID: 23070788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Cancer-Associated Hyaluronan Correlates With Diagnosis and Lymph Node Metastasis of Papillary Thyroid Cancer.
    Liu Q; Ye J; Liu B; Guo Q; Wang S; Liu Y; He Y; Du Y; Zhang G; Guo Q; Shen Y; Xu J; Liu H; Yang C
    Lab Invest; 2024 Aug; 104(8):102104. PubMed ID: 38945481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma.
    Xue L; Yan H; Chen Y; Zhang Q; Xie X; Ding X; Wang X; Qian Z; Xiao F; Song Z; Wu Y; Peng Y; Xu H
    BMC Cancer; 2019 Nov; 19(1):1094. PubMed ID: 31718595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene.
    Li T; Yang XD; Ye CX; Shen ZL; Yang Y; Wang B; Guo P; Gao ZD; Ye YJ; Jiang KW; Wang S
    Cell Cycle; 2017 Jan; 16(2):224-231. PubMed ID: 27929737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR7/CXCL12 axis is involved in lymph node and liver metastasis of gastric carcinoma.
    Xin Q; Zhang N; Yu HB; Zhang Q; Cui YF; Zhang CS; Ma Z; Yang Y; Liu W
    World J Gastroenterol; 2017 May; 23(17):3053-3065. PubMed ID: 28533662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of long non-coding RNA NR_036575.1 contributes to the proliferation and migration of papillary thyroid cancer.
    Sun W; Lan X; Wang Z; Dong W; He L; Zhang T; Zhang H
    Med Oncol; 2016 Sep; 33(9):102. PubMed ID: 27510368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CXCR4 and CXCR7 in papillary thyroid carcinoma and adjacent tissues and their relationship with pathologic indicators of tumor aggressiveness.
    Cao X; Zhu J; Li X; Ma Y; He Q
    Endocr J; 2022 Feb; 69(2):189-197. PubMed ID: 34588386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
    Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N
    Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
    Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 18. miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.
    Lv M; Zhang X; Li M; Chen Q; Ye M; Liang W; Ding L; Cai H; Fu D; Lv Z
    PLoS One; 2013; 8(7):e67591. PubMed ID: 23861775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.
    Wen Q; Zhao J; Bai L; Wang T; Zhang H; Ma Q
    Oncol Rep; 2015 Oct; 34(4):2202-10. PubMed ID: 26239517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway.
    Liao T; Wen D; Ma B; Hu JQ; Qu N; Shi RL; Liu L; Guan Q; Li DS; Ji QH
    Oncotarget; 2017 Feb; 8(7):11719-11728. PubMed ID: 28036290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.